ASX - By Stock
|
NEU |
Re:
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
|
|
hottod
|
59 |
21K |
61 |
08/08/25 |
08/08/25 |
ASX - By Stock
|
59
|
21K
|
61
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
|
|
hottod
|
59 |
21K |
25 |
08/08/25 |
08/08/25 |
ASX - By Stock
|
59
|
21K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
|
|
hottod
|
59 |
21K |
20 |
08/08/25 |
08/08/25 |
ASX - By Stock
|
59
|
21K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren adds SYNGAP1-related disorder to NNZ-2591 pipeline
|
|
hottod
|
59 |
21K |
68 |
08/08/25 |
08/08/25 |
ASX - By Stock
|
59
|
21K
|
68
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
24 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
58 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
58
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
66 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
66
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
11 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
28 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
47 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
47
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.2K |
540K |
24 |
06/08/25 |
06/08/25 |
ASX - By Stock
|
1.2K
|
540K
|
24
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.2K |
540K |
41 |
02/08/25 |
02/08/25 |
ASX - By Stock
|
1.2K
|
540K
|
41
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
65 |
01/08/25 |
01/08/25 |
ASX - By Stock
|
1.6K
|
833K
|
65
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
13K |
7.2M |
7 |
01/08/25 |
01/08/25 |
ASX - By Stock
|
13K
|
7.2M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
48 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
1.6K
|
833K
|
48
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY25 Trading Result (unaudited)
|
|
hottod
|
215 |
68K |
29 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
215
|
68K
|
29
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY25 Trading Result (unaudited)
|
|
hottod
|
215 |
68K |
61 |
30/07/25 |
30/07/25 |
ASX - By Stock
|
215
|
68K
|
61
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
hottod
|
13K |
7.2M |
39 |
25/07/25 |
25/07/25 |
ASX - By Stock
|
13K
|
7.2M
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.8K |
1.0M |
21 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
1.8K
|
1.0M
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.8K |
1.0M |
54 |
24/07/25 |
24/07/25 |
ASX - By Stock
|
1.8K
|
1.0M
|
54
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
1.0K |
533K |
19 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
1.0K
|
533K
|
19
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
1.0K |
533K |
18 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
1.0K
|
533K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
1.0K |
533K |
41 |
20/07/25 |
20/07/25 |
ASX - By Stock
|
1.0K
|
533K
|
41
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
1.0K |
533K |
28 |
19/07/25 |
19/07/25 |
ASX - By Stock
|
1.0K
|
533K
|
28
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
1.0K |
533K |
24 |
17/07/25 |
17/07/25 |
ASX - By Stock
|
1.0K
|
533K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
16K |
8.1M |
152 |
14/07/25 |
14/07/25 |
ASX - By Stock
|
16K
|
8.1M
|
152
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
16K |
8.1M |
139 |
11/07/25 |
11/07/25 |
ASX - By Stock
|
16K
|
8.1M
|
139
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
16K |
8.1M |
33 |
09/07/25 |
09/07/25 |
ASX - By Stock
|
16K
|
8.1M
|
33
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
hottod
|
249 |
138K |
51 |
05/07/25 |
05/07/25 |
ASX - By Stock
|
249
|
138K
|
51
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
16K |
8.1M |
38 |
04/07/25 |
04/07/25 |
ASX - By Stock
|
16K
|
8.1M
|
38
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
hottod
|
249 |
138K |
99 |
04/07/25 |
04/07/25 |
ASX - By Stock
|
249
|
138K
|
99
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
hottod
|
249 |
138K |
44 |
02/07/25 |
02/07/25 |
ASX - By Stock
|
249
|
138K
|
44
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
hottod
|
249 |
138K |
58 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
249
|
138K
|
58
|
|
ASX - By Stock
|
NEU |
Re:
M&A
|
|
hottod
|
249 |
138K |
108 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
249
|
138K
|
108
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Fourth Drug Program Progressing to Human Trials
|
|
hottod
|
9 |
4.9K |
31 |
30/06/25 |
30/06/25 |
ASX - By Stock
|
9
|
4.9K
|
31
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
hottod
|
328 |
186K |
24 |
29/06/25 |
29/06/25 |
ASX - By Stock
|
328
|
186K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Ann: First Subject Dosed in PKD Clinical Trial
|
|
hottod
|
61 |
31K |
14 |
28/06/25 |
28/06/25 |
ASX - By Stock
|
61
|
31K
|
14
|
|
ASX - By Stock
|
PYC |
Pipeline poised for data deluge?
|
|
hottod
|
2 |
1.3K |
23 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
2
|
1.3K
|
23
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Fourth Drug Program Progressing to Human Trials
|
|
hottod
|
9 |
4.9K |
18 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
9
|
4.9K
|
18
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
1.0K |
533K |
17 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
1.0K
|
533K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
28 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
1.6K
|
833K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
1.6K |
833K |
71 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
1.6K
|
833K
|
71
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
hottod
|
50 |
38K |
20 |
25/06/25 |
25/06/25 |
ASX - By Stock
|
50
|
38K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA
|
|
hottod
|
43 |
27K |
34 |
25/06/25 |
25/06/25 |
ASX - By Stock
|
43
|
27K
|
34
|
|
ASX - By Stock
|
PYC |
Re:
PYC Filed Another Patent
|
|
hottod
|
50 |
38K |
24 |
24/06/25 |
24/06/25 |
ASX - By Stock
|
50
|
38K
|
24
|
|
ASX - By Stock
|
PYC |
Re:
Ann: FDA Alignment on Registrational Trial Design RP11 Program
|
|
hottod
|
16 |
5.9K |
28 |
23/06/25 |
23/06/25 |
ASX - By Stock
|
16
|
5.9K
|
28
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
hottod
|
3.3K |
1.5M |
16 |
21/06/25 |
21/06/25 |
ASX - By Stock
|
3.3K
|
1.5M
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.8K |
1.0M |
49 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
1.8K
|
1.0M
|
49
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.8K |
1.0M |
41 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
1.8K
|
1.0M
|
41
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.8K |
1.0M |
31 |
19/06/25 |
19/06/25 |
ASX - By Stock
|
1.8K
|
1.0M
|
31
|
|